Skip to content
zameds

Tretinoin (Retin-a)

Tretinoin

Mc Pharma (Pty) Ltd

Registration

Applicant
Mc Pharma (Pty) Ltd
Certificate holder
Mc Pharma (Pty) Ltd
Registrations
1

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Retin-a 0,025%

EACH 1 g CONTAINS TRETINOIN 0,25 mg

0.5 mgCream, gelJ0350J/12/350Approved 10 February 2026RegisteredNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S5: Tretinoin

    • when intended for oral preparation.

    Consolidated Schedules 06 July 2026, line 9740

  • S3: Tretinoin

    • when intended for application to the skin.

    Consolidated Schedules 06 July 2026, line 4347

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C20H28O2300.40 g/mol

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid

Drag to rotate. Structure from PubChem CID 444795.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles